2011
DOI: 10.1172/jci60122
|View full text |Cite
|
Sign up to set email alerts
|

Do MDL-1+ cells play a broad role in acute inflammation?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Studies also demonstrated a strong expression of MDL-1 and DAP-12 in mature and differentiated monocytes/macrophages in contrast to undifferentiated bone marrow CD34 + stem cells or monocytes [ 11 ]. Functionally, MDL-1 acts as a signaling receptor for proinflammatory cytokine release [ 12 , 13 ] and is implicated in mediating multiple acute and chronic inflammatory diseases, including hemorrhagic fever, lethal shock, virus-induced brain damage, chronic obstructive pulmonary disease and development of autoimmune arthritis [ 14 18 ]. However, the correlation of MDL-1 with atherosclerosis and its behavior are still elusive and remain unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Studies also demonstrated a strong expression of MDL-1 and DAP-12 in mature and differentiated monocytes/macrophages in contrast to undifferentiated bone marrow CD34 + stem cells or monocytes [ 11 ]. Functionally, MDL-1 acts as a signaling receptor for proinflammatory cytokine release [ 12 , 13 ] and is implicated in mediating multiple acute and chronic inflammatory diseases, including hemorrhagic fever, lethal shock, virus-induced brain damage, chronic obstructive pulmonary disease and development of autoimmune arthritis [ 14 18 ]. However, the correlation of MDL-1 with atherosclerosis and its behavior are still elusive and remain unknown.…”
Section: Introductionmentioning
confidence: 99%
“…Activation of CLEC5A by the dengue virus (DENV) results in septic shock mediated by TNF and nitric oxide in mouse models [23,24]. Additionally, monoclonal antibodies against CLEC5A can inhibit plasma leakage and hemorrhagic episodes, and can reduce mortality (16).…”
Section: Introductionmentioning
confidence: 99%